Relief of menstrual symptoms and migraine with a single-tablet formulation of sumatriptan and naproxen sodium

Journal of Women's Health

Volumn 23, Issue 5, 2014, Pages 389-396

  Martin, Vincent T ^a   Ballard, Jeanne ^b,g   Diamond, Michael P ^c   Mannix, Lisa K ^d   Derosier, Frederick J ^e   Lener, Shelly E ^f   Krishen, Alok ^f   McDonald, Susan A ^f  

^a UNIVERSITY OF CINCINNATI MEDICAL CENTER   (United States)

^b IU Health Methodist   (United States)

^c MEDICAL COLLEGE OF GEORGIA   (United States)

^d Headache Associates   (United States)

^e Merz Pharmaceuticals LLC   (United States)

^f GLAXOSMITHKLINE   (United States)

^g CMIO (informatics) Roper Saint Francis   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NAPROXEN PLUS SUMATRIPTAN; PLACEBO;

ABDOMINAL PAIN; ADULT; ANALGESIA; ARTICLE; BACKACHE; BLOATING; DIZZINESS; DYSMENORRHEA; FATIGUE; FEMALE; HEADACHE; HUMAN; IRRITABILITY; MAJOR CLINICAL STUDY; MIGRAINE; NAUSEA; PARESTHESIA; PREMENSTRUAL SYNDROME; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); TABLET FORMULATION; TREATMENT RESPONSE; XEROSTOMIA;

ADOLESCENT; ADULT; ANALGESICS; DRUG COMBINATIONS; DYSMENORRHEA; FEMALE; HUMANS; LOGISTIC MODELS; MIGRAINE DISORDERS; NAPROXEN; ODDS RATIO; PREMENSTRUAL SYNDROME; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SEVERITY OF ILLNESS INDEX; SOCIOECONOMIC FACTORS; SUMATRIPTAN; TIME FACTORS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84899923208     PISSN: 15409996     EISSN: 1931843X     Source Type: Journal    
DOI: 10.1089/jwh.2013.4577     Document Type: Article

References (44)

1. Wang L, Wang X, Wang W, et al. Stress and dysmenorrhea: A population based prospective study. Occup Environ Med 2004;61:1021-1026.
2. Granella F, Sances G, Zanferrari C, Costa A, Martignoni E, Manzoni GC. Migraine without aura and reproductive life events: A clinical epidemiological study in 1300 women. Headache 1993;33:385-389.
3. Granella F, Sances G, Pucci E, Nappi RE, Ghiotto N, Napp G. Migraine with aura and reproductive life events: A case control study. Cephalalgia 2000;20:701-707.
4. Cupini LM, Matteis M, Troisi E, Calabresi P, Bernardi G, Silvestrini M. Sex-hormone-related events in migrainous females. A clinical comparative study between migraine with aura and migraine without aura. Cephalalgia 1995;15:140-144.
5. Mattsson P. Hormonal factors in migraine: A populationbased study of women aged 40 to 74 years. Headache 2003;43:27-35.
6. Koseoglu E, Nacar M, Talaslioglu A, Cetinkaya F. Epidemiological and clinical characteristics of migraine and tension type headache in 1146 females in Kayseri, Turkey. Cephalalgia 2003;23:381-388.
7. Couturier EG, Bomhof MA, Neven AK, van Duijn NP. Menstrual migraine in a representative Dutch population sample: Prevalence, disability and treatment. Cephalalgia 2003;23:302-308.
8. Davis AR, Westhoff CL. Primary dysmenorrhea in adolescent girls and treatment with oral contraceptives. J Pediatr Adolesc Gynecol 2001;14:3-8.
9. Unsal A, Ayranci U, Tozun M, Arsian G, Calik E. Prevalence of dysmenorrhea and its effect on quality of life among a group of female university students. Ups J Med Sci 2010;115:138-145.
10. Jamieson DJ, Steege JF. The prevalence of dysmenorrhea, dyspareunia, pelvic pain, and irritable bowel syndrome in primary care practices. Obstet Gynecol 1996;87:55-58.
11. Sundell G, Milsom I, Andersch B. Factors influencing the prevalence and severity of dysmenorrhea in young women. Br J Obstet Gynaecol 1990;97:588-594.
12. Weissman AM, Hartz AJ, Hansen MD, Johnson SR. The natural history of primary dysmenorrhea. BJOG 2004;111: 345-352.
13. Mannix LK. Menstrual-related pain conditions: Dysmenorrhea and migraine. J Womens Health (Larchmt) 2008; 17:879-891.
14. Mannix LK, Martin VT, Cady RK, et al. Combination treatment for menstrual migraine and dysmenorrhea using sumatriptan-naproxen: Two randomized controlled trials. Obstet Gynecol 2009;114:106-113.
15. Vincent K, Warnaby C, Stagg CJ, Moore J, Kennedy S, Tracey I. Dysmenorrhea is associated with central changes in otherwise healthy women. Pain 2011;152:1966-1975.
16. Giamberardino MA, Costantini R, Affaitati G, et al. Viscero-visceral hyperalgesia: Characterization in different clinical models. Pain 2010;151:307-322.
17. Headache classification subcommittee of the International Headache Society. The international classification of headache disorders, 2nd edition. Cephalalgia 2004; 24 Suppl 1: 9-160.
18. Naprosyn complete prescribing information. Nutley, NJ: Roche Laboratories Inc., 2006.
19. Treximet® Complete prescribing information. Research Triangle Park, NC: GlaxoSmithKline Inc., 2008.
20. Dawood MY. Primary dysmenorrhea: Advances in pathogenesis and management. Obstet Gynecol 2006;108:428-441.
21. Giffin NJ, Ruggiero L, Lipton RB, et al. Premonitory symptoms in migraine: An electronic diary study. Neurology 2003;60:935-940.
22. Quintela E, Castillo J, Munoz P, Pascual J. Premonitory and resolution symptoms in migraine: A prospective study in 100 unselected patients. Cephalalgia 2006;26:1051-1060.
23. Schoonman GG, Evers DJ, Terwindt GM, van Dijk JG, Ferrari MD. The prevalence of premonitory symptoms in migraine: A questionnaire study in 461 patients. Cephalalgia 2006;26:1209-1213.
24. Chen HM, Chen CH. Related factors and consequences of menstrual distress in adolescent girls with dysmenorrhea. Kaohsiung J Med Sci 2005;21:121-127.
25. Derman O, Kanbur NO, Tokur TE, Kutluk T. Premenstrual syndrome and associated symptoms in adolescent girls. Eur J Obstet Gynecol Reprod Biol 2004;116:201-206.
26. Daniels SE, Torri S, Desjardins PJ. Valdecoxib for treatment of primary dysmenorrhea. A randomized, doubleblind comparison with placebo and naproxen. J Gen Intern Med 2005;20:62-67.
27. Zhang WY, Li Wan Po A. Efficacy of minor analgesics in primary dysmenorrhea: A systematic review. Br J Obstet Gynaecol 1998;105:780-789.
28. Kori S, Littlefield D, Taylor D, et al. Pharmacokinetics of a single-tablet formulation of sumatriptan RT Technology™ and naproxen sodium [abstract]. Cephalalgia 2005;25:933. Abstract.
29. Goadsby PJ. The pharmacology of headache. Prog Neurobiol 2000;62:509-525.
30. Sarchielli P, Alberti A, Vaianella L, et al. Chemokine levels in the jugular venous blood of migraine without aura patients during attacks. Headache 2004;44:961-968.
31. Sarchielli P, Alberti A, Codini M, Floridi A, Gallai V. Nitric oxide metabolites, prostaglandins and trigeminal vasoactive peptides in internal jugular vein blood during spontaneous migraine attacks. Cephalalgia 2000;20: 907-918.
32. Nattero G, Allais G, De Lorenzo C, et al. Menstrual migraine: New biochemical and psychological aspects. Headache 1988;28:103-107.
33. Benedetto C. Eicosanoids in primary dysmenorrhea, endometriosis and menstrual migraine. Gynecol Endocrinol 1989;3:71-94.
34. Jaobbour HN, Sales KJ, Smith OP, Battersby S, Boddy SC. Prostaglandin receptors are mediators of vascular function in endometrial pathologies. Mol Cell Endocrinol 2006; 252:191-200.
35. Chan WY, Dawood MY. Prostaglandin levels in menstrual fluid of nondysmenorrheic and of dysmenorrheic subjects with and without oral contraceptive or ibuprofen therapy. Adv Prostaglandin Thromboxane Res 1980;8:1443-1447.
36. Nattero G, Allais G, De Lorenzo C, et al. Relevance of prostaglandins in true menstrual migraine. Headache 1989; 29:232-237.
37. Daniels S, Robbins J, West CR, Nemeth MA. Celecoxib in the treatment of primary dysmenorrhea: Results from two randomized, double-blind, active- and placebo-controlled crossover studies. Clin Ther 2009;31:1192-1208.
38. Chantler I, Mitchell D, Fuller A. Diclofenac potassium attenuates dysmenorrhea and restores exercise performance in women with primary dysmenorrhea. J Pain 2009;10: 191-200.
39. Suthisisang C, Poolsup N, Kittikulsuth W, Pudchakan P, Wiwatpanich P. Efficacy of low-dose ibuprofen in acute migraine treatment: Systematic review and meta-analysis. Ann Pharmacother 2007;41:1782-1791.
40. Saper J, Dahlof C, So Y, et al. Rofecoxib in the acute treatment of migraine: A randomized controlled clinical trial. Headache 2006;46:264-275.
41. Suthisisang CC, Poolsup N, Suksomboon N, Lertpipopmetha V, Tepwitukgid B. Meta-analysis of the efficacy and safety of naproxen sodium in the acute treatment of migraine. Headache 2010;50:808-818.
42. Loo CY, Tan HJ, Teh HS, Raymond AA. Randomised, open label, controlled trial of celecoxib in the treatment of acute migraine. Singapore Med J 2007;48:834-839.
43. Durham PL, Vause CV, Derosier F, McDonald S, Cady R, Martin V. Changes in salivary prostaglandin levels during menstrual migraine with associated dysmenorrhea. Headache 2010;50:844-851.
44. Tietjen GE, Bushnell CD, Herial NA, Utley C, White L, Hafeez F. Endometriosis is associated with prevalence of comorbid conditions in migraine. Headache 2007;47:1069-1078.